caLogo

FEINFOCUS (Stamford, CT), a global supplier of Microfocus x-ray inspection systems and tube technology, has agreed to be acquired by COMET AG (Flamatt, Switzerland), a supplier of conventional x-ray tubes for non-destructive testing (NDT), security, analytics, food inspection/irradiation and semiconductor applications. FEINFOCUS is known for microfocus and nanofocus x-ray inspection for electronics assembly, semiconductor and medical device industries, as well as NDT and the emerging micro-electromechanical systems (MEMS) markets. 

 

This acquisition represents a partnering of microfocus and conventional x-ray technology.  A provider of sealed x-ray tube manufacturing, COMET will be acquiring a provider of demountable, or open, x-ray tube technology. 

 

Both companies seek to capitalize on continuing opportunities from industry trends toward smaller feature sizes, 3-D computed tomography (CT) applications and the departure from film-based imaging. 

 

FEINFOCUS chief executive officer Lance A. Scott said, "With well over 50 years' experience in high voltage/high vacuum x-ray tube manufacturing, COMET's proprietary know-how will accelerate FEINFOCUS' development of next generation microfocus and nanofocus X-ray technology. FEINFOCUS' proprietary system development know-how and award-winning service support will extend COMET's ability to offer proven sub-system solutions to its valued customer base." 

 

Organizationally, there is little duplication between the two companies. FEINFOCUS will immediately expand its presence in Asia through COMET's Shanghai office and COMET will take advantage of FEINFOCUS' North American presence in Connecticut and California. 

 

FEINFOCUS was founded in 1982 and is headquartered in Garbsen, Germany. COMET was founded in 1948. In 2003, COMET employed a staff of 245 in its headquarters and its three subsidiaries in the US, France and China. 
 

www.feinfocus.com

 

www.comet.ch

 

Copyright 2004, UP Media Group. All rights reserved.
Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedInPrint Article
Don't have an account yet? Register Now!

Sign in to your account